No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with denys-drash syndrome

D. Perotti, P. Mondini, R. Giardini, A. Ferrari, M. Massimino, F. Gambirasio, M. A. Pierotti, F. Fossati-Bellani, P. Radice

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: We previously reported the case of a patient affected with Denys-Drash syndrome (DDS), who developed disseminated EBV-related Burkitt's lymphoma (BL) after kidney transplantation. Here, we describe the molecular characterisation of the WTI gene in the constitutional and turnour DNA of this patient. Patients and methods: WTI exons 2 to 10 were sequenced in constitutional and tumour DNAs. By Southern blotting the latter was also investigated for the presence of gene rearrangements. Gene expression analysis in tumour cells was performed by reverse transcriptase-polymerase chain reaction (RT-PCR). Results: A germline missense mutation affecting one of the zinc finger domains of the gene, and previously reported in other DDS cases, was observed. No alterations of the constitutionally wild-type WTI allele and no expression of the gene were observed in BL cells. A small group of BLs from other paediatric patients showed a variable expression of WTI. Conclusions: Our findings indicate that WT1 is unlikely to be involved in the onset of BL in our case. However, a possible role of the gene in at least a subset of these lymphoproliferative diseases may be suggested.

Original languageEnglish
Pages (from-to)627-631
Number of pages5
JournalAnnals of Oncology
Volume9
Issue number6
DOIs
Publication statusPublished - Jun 1998

Fingerprint

Denys-Drash Syndrome
Burkitt Lymphoma
Genes
Gene Expression
Germ-Line Mutation
Gene Rearrangement
DNA
Zinc Fingers
Missense Mutation
Southern Blotting
Reverse Transcriptase Polymerase Chain Reaction
Human Herpesvirus 4
Kidney Transplantation
Exons
Neoplasms
Alleles
Pediatrics

Keywords

  • Burkitt's lymphoma
  • Denys-Drash syndrome
  • WTI

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with denys-drash syndrome. / Perotti, D.; Mondini, P.; Giardini, R.; Ferrari, A.; Massimino, M.; Gambirasio, F.; Pierotti, M. A.; Fossati-Bellani, F.; Radice, P.

In: Annals of Oncology, Vol. 9, No. 6, 06.1998, p. 627-631.

Research output: Contribution to journalArticle

Perotti, D. ; Mondini, P. ; Giardini, R. ; Ferrari, A. ; Massimino, M. ; Gambirasio, F. ; Pierotti, M. A. ; Fossati-Bellani, F. ; Radice, P. / No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with denys-drash syndrome. In: Annals of Oncology. 1998 ; Vol. 9, No. 6. pp. 627-631.
@article{516dc7ebbc7d4d8294227572db8eb04c,
title = "No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with denys-drash syndrome",
abstract = "Background: We previously reported the case of a patient affected with Denys-Drash syndrome (DDS), who developed disseminated EBV-related Burkitt's lymphoma (BL) after kidney transplantation. Here, we describe the molecular characterisation of the WTI gene in the constitutional and turnour DNA of this patient. Patients and methods: WTI exons 2 to 10 were sequenced in constitutional and tumour DNAs. By Southern blotting the latter was also investigated for the presence of gene rearrangements. Gene expression analysis in tumour cells was performed by reverse transcriptase-polymerase chain reaction (RT-PCR). Results: A germline missense mutation affecting one of the zinc finger domains of the gene, and previously reported in other DDS cases, was observed. No alterations of the constitutionally wild-type WTI allele and no expression of the gene were observed in BL cells. A small group of BLs from other paediatric patients showed a variable expression of WTI. Conclusions: Our findings indicate that WT1 is unlikely to be involved in the onset of BL in our case. However, a possible role of the gene in at least a subset of these lymphoproliferative diseases may be suggested.",
keywords = "Burkitt's lymphoma, Denys-Drash syndrome, WTI",
author = "D. Perotti and P. Mondini and R. Giardini and A. Ferrari and M. Massimino and F. Gambirasio and Pierotti, {M. A.} and F. Fossati-Bellani and P. Radice",
year = "1998",
month = "6",
doi = "10.1023/A:1008248905766",
language = "English",
volume = "9",
pages = "627--631",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "6",

}

TY - JOUR

T1 - No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with denys-drash syndrome

AU - Perotti, D.

AU - Mondini, P.

AU - Giardini, R.

AU - Ferrari, A.

AU - Massimino, M.

AU - Gambirasio, F.

AU - Pierotti, M. A.

AU - Fossati-Bellani, F.

AU - Radice, P.

PY - 1998/6

Y1 - 1998/6

N2 - Background: We previously reported the case of a patient affected with Denys-Drash syndrome (DDS), who developed disseminated EBV-related Burkitt's lymphoma (BL) after kidney transplantation. Here, we describe the molecular characterisation of the WTI gene in the constitutional and turnour DNA of this patient. Patients and methods: WTI exons 2 to 10 were sequenced in constitutional and tumour DNAs. By Southern blotting the latter was also investigated for the presence of gene rearrangements. Gene expression analysis in tumour cells was performed by reverse transcriptase-polymerase chain reaction (RT-PCR). Results: A germline missense mutation affecting one of the zinc finger domains of the gene, and previously reported in other DDS cases, was observed. No alterations of the constitutionally wild-type WTI allele and no expression of the gene were observed in BL cells. A small group of BLs from other paediatric patients showed a variable expression of WTI. Conclusions: Our findings indicate that WT1 is unlikely to be involved in the onset of BL in our case. However, a possible role of the gene in at least a subset of these lymphoproliferative diseases may be suggested.

AB - Background: We previously reported the case of a patient affected with Denys-Drash syndrome (DDS), who developed disseminated EBV-related Burkitt's lymphoma (BL) after kidney transplantation. Here, we describe the molecular characterisation of the WTI gene in the constitutional and turnour DNA of this patient. Patients and methods: WTI exons 2 to 10 were sequenced in constitutional and tumour DNAs. By Southern blotting the latter was also investigated for the presence of gene rearrangements. Gene expression analysis in tumour cells was performed by reverse transcriptase-polymerase chain reaction (RT-PCR). Results: A germline missense mutation affecting one of the zinc finger domains of the gene, and previously reported in other DDS cases, was observed. No alterations of the constitutionally wild-type WTI allele and no expression of the gene were observed in BL cells. A small group of BLs from other paediatric patients showed a variable expression of WTI. Conclusions: Our findings indicate that WT1 is unlikely to be involved in the onset of BL in our case. However, a possible role of the gene in at least a subset of these lymphoproliferative diseases may be suggested.

KW - Burkitt's lymphoma

KW - Denys-Drash syndrome

KW - WTI

UR - http://www.scopus.com/inward/record.url?scp=0031847398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031847398&partnerID=8YFLogxK

U2 - 10.1023/A:1008248905766

DO - 10.1023/A:1008248905766

M3 - Article

C2 - 9681076

AN - SCOPUS:0031847398

VL - 9

SP - 627

EP - 631

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 6

ER -